Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 (“INTEGRA”) study at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco.
Go to Source
https://medicalxpress.com/rss-feed/